Titel

Merkliste
1 Ergebnisse

Phase I/II study of azacitidine and capecitabine/oxaliplati..:

Overman, Michael ; Morris, Van ; Moinova, Helen...
info:eu-repo/semantics/altIdentifier/doi/10.18632/oncotarget.11317. , 2016

Link: https://hal.umontpellier.fr/hal-02298775

RT Journal
T1 <Title>Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftccsdartic:oai:HAL:hal-02298775v1&Exemplar=1&LAN=DE
				
A1 Overman, Michael
A1 Morris, Van
A1 Moinova, Helen
A1 Manyam, Ganiraju
A1 Ensor, Joe
A1 Lee, Michael
A1 Eng, Cathy
A1 Kee, Bryan
A1 Fogelman, David
A1 Shroff, Rachna
A1 LaFramboise, Thomas
A1 Mazard, Thibault
A1 Feng, Tian
A1 Hamilton, Stanley
A1 Broom, Bradley
A1 Lutterbaugh, James
A1 Issa, Jean-Pierre
A1 Markowitz, Sanford
A1 Kopetz, Scott
PB HAL CCSD; Impact journals
YR 2016
K1 CIMP
K1 azacitidine
K1 colorectal cancer
K1 methylation
K1 vimentin
K1 MESH: Adult
K1 MESH: Aged
K1 MESH: Drug Resistance
K1 Neoplasm
K1 MESH: Female
K1 MESH: Humans
K1 MESH: Male
K1 MESH: Middle Aged
K1 MESH: Organoplatinum Compounds
K1 MESH: Oxaliplatin
K1 MESH: Vimentin
K1 MESH: Antineoplastic Combined Chemotherapy Protocols
K1 MESH: Azacitidine
K1 MESH: Biomarkers
K1 Tumor
K1 MESH: Capecitabine
K1 MESH: Colorectal Neoplasms
K1 MESH: CpG Islands
K1 MESH: DNA Methylation
K1 MESH: Disease-Free Survival
K1 [SDV.CAN]Life Sciences [q-bio]/Cancer
K1 [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology
K1 [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology
JF info:eu-repo/semantics/altIdentifier/doi/10.18632/oncotarget.11317
LK http://dx.doi.org/https://hal.umontpellier.fr/hal-02298775
DO https://hal.umontpellier.fr/hal-02298775
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)